Johnston, Adam Comment on Effects of Tax Law Change on Health Fraud Settlement Costs
February 23, 2018
BNA Health Care Daily
Partners Pam Johnston and Fred Adam are quoted in a BNA Health Care Daily Report article, “Tax Law Change May Raise Health Fraud Settlement Costs,” about the possible effects of a change in the tax rules governing the deduction of health care fraud settlement amounts.
A provision of the new tax reform act, signed into law on Dec. 22, requires a settling agency, like the Department of Justice, to state what portion of a False Claim Act settlement can be deducted as a business expense because it qualifies as restitution. The tax provision also eliminates certain types of previously deductible expenses related to FCA settlements, like government investigation expenses and interest.
Johnston said the new deductibility rules will “materially affect negotiations with the DOJ” over FCA settlements because limiting the deduction of the settlement amount could make the settlement less attractive.
Adam said the new provision “increases costs for both sides, for taxpayers and for the government.”
Subscription required to read.
A provision of the new tax reform act, signed into law on Dec. 22, requires a settling agency, like the Department of Justice, to state what portion of a False Claim Act settlement can be deducted as a business expense because it qualifies as restitution. The tax provision also eliminates certain types of previously deductible expenses related to FCA settlements, like government investigation expenses and interest.
Johnston said the new deductibility rules will “materially affect negotiations with the DOJ” over FCA settlements because limiting the deduction of the settlement amount could make the settlement less attractive.
Adam said the new provision “increases costs for both sides, for taxpayers and for the government.”
Subscription required to read.
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."